Article
BRCA2 carriers with male breast cancer show elevated tumour methylation.
BMC cancer - 11 Sept 2017
Deb Siddhartha, Gorringe Kylie L, Pang Jia-Min B, Byrne David J, Takano Elena A, Dobrovic Alexander, Fox Stephen B
Abstract excerpt
BACKGROUND: Male breast cancer (MBC) represents a poorly characterised group of tumours, the management of which is largely based on practices established for female breast cancer. However, recent studies demonstrate biological and molecular differences likely to impact on tumour behaviour and therefore patient outcome. The aim of this study was to investigate methylation of a panel of commonly methylated breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
